Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
D006916:5-Hydroxytryptophan / Q000378:metabolism / Q000494:pharmacology*; D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology*; D008297:Male; D008750:Methyldopa / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology*; D011955:Receptors, Drug; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D013268:Stimulation, Chemical; D013315:Stress, Psychological; D014364:Tryptophan / Q000378:metabolism / Q000494:pharmacology*; D014443:Tyrosine / Q000494:pharmacology
D000081:Acetamides; D000928:Antidepressive Agents; D002395:Catecholamines; D006834:Hydrazines; D011955:Receptors, Drug; D012701:Serotonin; D014443:Tyrosine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D007099:Imipramine; D010134:Fenclonine; D009526:Nialamide